Epidemiology — MCQs

Epidemiology Indian Medical PG Practice Questions and MCQs

Question 381: What is the most important factor for a test to be considered a good screening test?

A. Specificity
B. Sensitivity (Correct Answer)
C. Reliability
D. Predictive value

Explanation: ### Explanation **Why Sensitivity is the Correct Answer:** The primary objective of a **screening test** is to detect a disease in its early, asymptomatic stage within a large population. For a screening test to be effective, it must have high **Sensitivity**, which is the ability of a test to correctly identify all those who have the disease (True Positives). A high sensitivity ensures a **low False Negative rate**, meaning very few cases are missed. In public health, missing a case (False Negative) is often more dangerous than a False Positive, as the goal is to cast a wide net to capture potential cases for further confirmation. **Analysis of Incorrect Options:** * **Specificity (A):** While important, specificity is the hallmark of a **diagnostic test**. It aims to correctly identify those without the disease (True Negatives). High specificity minimizes False Positives, which is crucial *after* a positive screening result to confirm the diagnosis. * **Reliability (C):** Also known as precision or repeatability, this refers to the consistency of results when the test is repeated. While necessary for any laboratory test, it does not determine the test's ability to discriminate between health and disease. * **Predictive Value (D):** Positive Predictive Value (PPV) depends heavily on the **prevalence** of the disease in the population. While clinically useful for a physician to tell a patient their likelihood of having the disease, it is not the inherent property that defines a "good" screening tool. **High-Yield Clinical Pearls for NEET-PG:** * **Screening Test:** High Sensitivity, high Negative Predictive Value (NPV), used on asymptomatic people, and should be cheap/safe. * **Diagnostic Test:** High Specificity, high Positive Predictive Value (PPV), used on symptomatic people or those who screened positive. * **Yield:** The amount of previously undiagnosed disease recognized as a result of screening. * **Iceberg Phenomenon:** Screening is used to uncover the "submerged portion" (undiagnosed/asymptomatic cases) of the iceberg.

Question 382: All of the following infections have carrier states, EXCEPT:

A. Measles (Correct Answer)
B. Diphtheria
C. Typhoid
D. Gonorrhea

Explanation: **Explanation:** The concept of a **carrier state** refers to an individual who harbors a specific infectious agent without having clinical disease but serves as a potential source of infection for others. **1. Why Measles is the Correct Answer:** Measles is caused by a highly contagious virus that follows an **"all-or-none" phenomenon**. Once infected, an individual either develops the clinical disease or gains lifelong immunity. There is **no chronic or subclinical carrier state** in Measles. Furthermore, the virus does not persist in the body after the acute phase (except in the rare, late-onset complication of SSPE, which is not considered a carrier state for transmission). **2. Analysis of Incorrect Options:** * **Diphtheria:** Known for having both **convalescent and healthy carriers**. Carriers are more common than clinical cases and are significant reservoirs for spreading the infection in the community. * **Typhoid (Enteric Fever):** Famous for the **chronic carrier state** (e.g., "Typhoid Mary"). The bacteria (*S. typhi*) can persist in the gallbladder or biliary tract for years, shedding the organism in feces. * **Gonorrhea:** Frequently presents with **asymptomatic/subclinical carriers**, especially in females. These individuals do not show symptoms but can transmit the infection to sexual partners. **High-Yield Clinical Pearls for NEET-PG:** * **Diseases with NO carrier state:** Measles, Pertussis, Rabies, Smallpox, and Plague. * **Epidemiological Importance:** Diseases without a carrier state are generally easier to eradicate (e.g., Smallpox) because there is no "hidden" reservoir in the population. * **Incubatory Carrier:** Someone who sheds the pathogen during the incubation period (e.g., Measles, Mumps, Polio, Hepatitis B). Note: While Measles has an *incubatory* phase of shedding, it does not have a *chronic* carrier state.

Question 383: Which of the following is not a live attenuated vaccine?

A. Polio Sabin vaccine
B. Schwarz measles vaccine
C. BCG vaccine
D. Pertussis vaccine (Correct Answer)

Explanation: The correct answer is **D. Pertussis vaccine**. ### **Explanation** The classification of vaccines is a high-yield topic in NEET-PG. Vaccines are broadly categorized into live attenuated, killed (inactivated), toxoids, and subunit vaccines. 1. **Why Pertussis is the correct answer:** The Pertussis vaccine is a **killed (inactivated) vaccine**. In the traditional DPT (Diphtheria, Pertussis, Tetanus) vaccine, the pertussis component consists of whole-cell killed *Bordetella pertussis*. Modern acellular pertussis (aP) vaccines are subunit vaccines containing purified antigens. It is never administered as a live attenuated preparation. 2. **Why other options are incorrect:** * **Polio Sabin (Option A):** This is the Oral Polio Vaccine (OPV), which is a classic **live attenuated** vaccine. In contrast, the Salk vaccine (IPV) is killed. * **Schwarz Measles (Option B):** The Schwarz strain is a standard **live attenuated** strain used globally for measles immunization. * **BCG (Option C):** Bacillus Calmette–Guérin is a **live attenuated** bacterial vaccine derived from *Mycobacterium bovis*. ### **High-Yield Clinical Pearls for NEET-PG** * **Mnemonic for Live Vaccines:** "**B**oy **R**omeo **G**ive **M**y **L**ove **T**o **S**ite **V**ia **I**njection" (**B**CG, **R**otavirus, **G**umbaro/not human, **M**MR, **L**ive Typhoid/Ty21a, **T**ularemia, **S**mallpox, **V**aricella, **I**nfluenza/Nasal). * **Yellow Fever:** Uses the **17D strain**, which is live attenuated. * **Contraindications:** Live vaccines are generally contraindicated in **pregnancy** and **immunocompromised** individuals (except HIV patients before the symptomatic stage for certain vaccines like BCG/Measles). * **Storage:** Most live vaccines are heat-sensitive and must be stored in the lower part of the refrigerator (2°C to 8°C) or frozen (OPV).

Question 384: In a population of 100,000 individuals surveyed over one year, 100 cases tested positive for malaria on a thick smear. Among these positive cases, 20 developed complications and 10 died. What is the Annual Parasite Incidence (API)?

A. 1 per 1000 (Correct Answer)
B. 2 per 1000
C. 10 per 1000
D. 20 per 1000

Explanation: ### Explanation **1. Why Option A is Correct:** The **Annual Parasite Incidence (API)** is a key epidemiological indicator used under the National Vector Borne Disease Control Programme (NVBDCP) to measure the incidence of malaria in a community. It is calculated using the formula: $$\text{API} = \frac{\text{Total number of positive slides (confirmed cases) during the year}}{\text{Total population under surveillance}} \times 1000$$ **Calculation:** * Total positive cases = 100 * Total population = 100,000 * $\text{API} = (100 / 100,000) \times 1000 = \mathbf{1 \text{ per } 1000}$ **2. Why Other Options are Incorrect:** * **Option B (2 per 1000):** This value would result if there were 200 positive cases. It does not reflect the data provided. * **Option C (10 per 1000):** This is a mathematical distractor. * **Option D (20 per 1000):** This incorrectly uses the number of complications (20) as the numerator. The number of complications is used to calculate morbidity rates, not API. **Note on Mortality:** The 10 deaths mentioned in the question would be used to calculate the **Case Fatality Rate** (Deaths/Cases × 100 = 10%), which is a measure of disease severity, not incidence. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **API Significance:** An API of **$\geq$ 2** is the threshold used to classify an area as "high risk," requiring intensified indoor residual spraying (IRS). * **ABER (Annual Blood Examination Rate):** Measures the efficiency of surveillance. It should ideally be **$\geq$ 10%**. * **Slide Positivity Rate (SPR):** (Total positive slides / Total slides examined) × 100. * **Gold Standard:** While Rapid Diagnostic Tests (RDTs) are common, the **thick smear** remains the gold standard for parasite detection/quantification in epidemiological surveys.

Question 385: Which statement is false regarding cohort studies?

A. Incidence can be measured
B. Used to study chronic diseases
C. Expensive
D. Always prospective (Correct Answer)

Explanation: **Explanation:** In epidemiology, a **Cohort Study** is an observational analytical study where a group of individuals (the cohort) is defined based on the presence or absence of exposure to a particular factor and followed over time to observe the development of an outcome. **Why Option D is the Correct Answer (The False Statement):** While most cohort studies are prospective, they are **not always prospective**. Cohort studies can be classified into three types: 1. **Prospective Cohort:** Starts in the present and follows subjects into the future. 2. **Retrospective (Historical) Cohort:** Uses past records (e.g., medical files from 10 years ago) to identify exposure and follows the timeline forward to the present to see the outcome. 3. **Ambispective Cohort:** Combines both retrospective and prospective elements. **Analysis of Other Options:** * **A. Incidence can be measured:** This is a hallmark of cohort studies. Since we start with disease-free individuals and follow them over time, we can calculate the number of *new cases* (Incidence). * **B. Used to study chronic diseases:** Cohort studies are excellent for studying chronic conditions or diseases with long induction periods, provided the researcher has the resources for long-term follow-up. * **C. Expensive:** Because they require large sample sizes and long follow-up periods (often years), they are significantly more expensive and time-consuming than case-control studies. **High-Yield NEET-PG Pearls:** * **Directionality:** Cohort studies move from **Cause to Effect** (Forward-looking). * **Risk Assessment:** The primary measure of association in a cohort study is **Relative Risk (RR)** and **Attributable Risk (AR)**. * **Best For:** Studying **rare exposures** (e.g., a specific chemical leak) rather than rare diseases. * **Selection Bias:** Cohort studies are prone to **"Loss to follow-up"** (attrition bias).

Question 386: All of the following are true about Typhoid EXCEPT:

A. Incubation period is 10 to 14 days
B. It is most common among males
C. Carriers can be treated by Ampicillin
D. The highest incidence occurs in the 30-40 years age group (Correct Answer)

Explanation: **Explanation:** The correct answer is **D**. In endemic areas like India, Typhoid fever (Enteric fever) primarily affects children and young adults. The highest incidence is typically observed in the **5-19 years age group**, not the 30-40 years group. By the fourth decade of life, many individuals have acquired natural immunity through repeated subclinical exposures. **Analysis of other options:** * **Option A:** The incubation period for *Salmonella typhi* is classically **10 to 14 days**, though it can range from 3 to 21 days depending on the host's health and the size of the infectious dose. * **Option B:** Epidemiological data consistently shows that Typhoid is **more common among males**. This is often attributed to greater outdoor activity, increased consumption of street food, and higher exposure to contaminated water sources. * **Option C:** **Ampicillin** (often combined with Probenecid) or Amoxicillin for 4–6 weeks is a standard treatment for the biliary carrier state, provided the gallbladder is not diseased. (Note: Ciprofloxacin is also used, but Ampicillin remains a textbook-correct option for carriers). **High-Yield Clinical Pearls for NEET-PG:** * **Reservoir:** Man is the only known reservoir. * **Chronic Carrier:** Defined as an individual excreting bacilli for **more than one year**. The most famous example is "Typhoid Mary." * **Nidus of Infection:** In chronic carriers, the organism persists in the **gallbladder** (associated with gallstones) or the urinary tract (associated with *Schistosoma haematobium*). * **Diagnostic Timelines:** Use the **BASU** mnemonic: **B**lood culture (1st week), **A**ntibody/Widal (2nd week), **S**tool culture (3rd week), **U**rine culture (4th week).

Question 387: The person, animal, object, or substance from which an infectious agent passes or is disseminated by a host is called what?

A. Reservoir
B. Source (Correct Answer)
C. Carrier
D. Homologous reservoir

Explanation: ### Explanation The correct answer is **Source**. In epidemiology, it is crucial to distinguish between where an agent normally lives and where it actually comes from to infect a host. **1. Why "Source" is correct:** The **Source of infection** is defined as the person, animal, object, or substance from which an infectious agent passes directly to a host. It represents the "immediate" origin of the infection. For example, in a food poisoning outbreak caused by contaminated salad, the salad is the *source*, even if the *reservoir* of the bacteria is a human carrier who prepared it. **2. Why other options are incorrect:** * **Reservoir:** This is the natural habitat (human, animal, or environmental) in which an infectious agent lives, grows, and multiplies. While the source and reservoir can be the same (e.g., in Syphilis, a human is both), they are often different (e.g., in Hookworm, the reservoir is man, but the source is the soil). * **Carrier:** A carrier is an infected person or animal that harbors a specific infectious agent without having clinical disease and serves as a potential source of infection. It is a *type* of reservoir, not the definition of the dissemination point itself. * **Homologous reservoir:** This is a distractor term. In epidemiology, we generally classify reservoirs as Human, Animal, or Non-living. **Clinical Pearls for NEET-PG:** * **Source = Reservoir:** Occurs in diseases like Measles, Mumps, and STIs where there is no environmental stage or animal vector. * **Source ≠ Reservoir:** Occurs in Hookworm (Reservoir: Man; Source: Soil) and Tetanus (Reservoir: Soil; Source: Contaminated object). * **Case vs. Carrier:** A 'Case' shows clinical symptoms; a 'Carrier' does not but can still spread the disease. Carriers are often more dangerous epidemiologically because their activities are not restricted by illness.

Question 388: Severity of disease is assessed by:

A. Secondary attack rate
B. Case fatality rate (Correct Answer)
C. Prevalence rate
D. Incidence rate

Explanation: **Explanation:** The severity of a disease is best reflected by its **Case Fatality Rate (CFR)**. CFR measures the proportion of people diagnosed with a specific disease who die from it within a specified period. Mathematically, it is (Total deaths from disease / Total diagnosed cases) × 100. It serves as an index of the **virulence** of an infectious agent and the killing power of a disease. **Analysis of Options:** * **Case Fatality Rate (Correct):** It directly quantifies the risk of dying once the disease is contracted. A high CFR (e.g., Rabies ~100%, Ebola ~50%) indicates a highly severe disease. * **Secondary Attack Rate (SAR):** This measures the **communicability** or infectivity of a disease within a closed group (like a household) after the introduction of a primary case. It does not reflect clinical severity. * **Incidence Rate:** This measures the number of **new cases** occurring in a population at risk during a specific period. It reflects the rate of transmission and risk of acquisition, not the outcome or severity. * **Prevalence Rate:** This measures the **total number of cases** (old + new) in a population at a given point in time. It is influenced by both incidence and duration of the disease. **High-Yield NEET-PG Pearls:** * **CFR** is a ratio, but traditionally expressed as a percentage. * **CFR is inversely related to prognosis:** Higher CFR means a poorer prognosis. * **Virulence** is clinically measured by CFR. * **Pathogenicity** is the ability of an agent to produce visible clinical disease (not necessarily death).

Question 389: If the same individual participates in both the study and experimental group (i.e., the patient serves as their own control), what is this design called?

A. Crossover study (Correct Answer)
B. Case-control study
C. Cohort study
D. Experimental study

Explanation: ### Explanation **Correct Answer: A. Crossover study** In a **Crossover Study**, each participant receives two or more treatments in a specific sequence. The key feature is that **the patient serves as their own control**. This design eliminates "inter-individual variation" (differences between people) because the baseline characteristics (genetics, age, lifestyle) remain identical for both the treatment and control phases. Typically, a **washout period** is included between the two phases to ensure that the effects of the first drug are completely eliminated before the second drug is administered, preventing a "carry-over effect." **Why other options are incorrect:** * **B. Case-control study:** This is a retrospective observational study that compares individuals with a disease (cases) to those without (controls) to look for prior exposure. The groups consist of different individuals. * **C. Cohort study:** This is a longitudinal observational study where a group is followed forward in time to see who develops the outcome. It compares exposed vs. unexposed groups, not the same individual against themselves. * **D. Experimental study:** While a crossover study is a *type* of experimental study (specifically an RCT), "Experimental study" is a broad category. The question asks for the specific design where the patient is their own control, making "Crossover study" the most precise answer. **High-Yield Clinical Pearls for NEET-PG:** * **Advantage:** Requires a **smaller sample size** than a parallel-group RCT to achieve the same statistical power. * **Limitation:** It cannot be used for conditions that are "cured" by the first treatment (e.g., acute infections or surgeries) or for unstable/progressive diseases. * **Washout Period:** Essential to prevent the **Carry-over effect**. * **Statistical Test:** Since the data is paired (same person), a **Paired t-test** is often used for analysis.

Question 390: All of the following factors contribute to the resurgence of malaria, except:

A. Drug resistance in the host (Correct Answer)
B. Drug resistance in the parasite
C. Drug resistance in vectors
D. Antigenic variations in the parasite

Explanation: ### Explanation The resurgence of malaria refers to the return of the disease to areas where it was previously controlled or eliminated. To understand this, we must distinguish between the **host (human)**, the **parasite (*Plasmodium*)**, and the **vector (*Anopheles* mosquito)**. **1. Why "Drug resistance in the host" is the correct answer:** Resistance is a biological phenomenon occurring in the **infecting organism** (parasite) or the **carrier** (vector), not the human host. Humans do not develop "drug resistance"; rather, they may develop *immunity* or exhibit *pharmacogenetic variations* (like G6PD deficiency) that affect drug metabolism. Since the host's physiological makeup doesn't "resist" the drug in a way that causes disease resurgence, this option is the odd one out. **2. Analysis of Incorrect Options:** * **Drug resistance in the parasite:** This is a major driver of resurgence. When *Plasmodium falciparum* develops resistance to first-line drugs like Chloroquine or Artemisinin, treatment fails, leading to a persistent reservoir of infection in the community. * **Insecticide resistance in vectors:** When *Anopheles* mosquitoes develop resistance to insecticides (like DDT or Pyrethroids) used in Indoor Residual Spraying (IRS) or Long-Lasting Insecticidal Nets (LLINs), vector control fails, leading to increased transmission. * **Antigenic variations in the parasite:** *Plasmodium* can change its surface proteins (e.g., PfEMP1). This allows it to evade the human immune system, leading to repeated infections and complicating vaccine development, thereby contributing to the disease's persistence. **High-Yield Clinical Pearls for NEET-PG:** * **Triple Whammy of Resurgence:** Resistance in the parasite (to drugs), resistance in the vector (to insecticides), and human factors (migration/refusal of IRS). * **Most common cause of technical failure** in malaria control: Vector resistance to insecticides. * **Urban Malaria:** Primarily transmitted by *Anopheles stephensi*. * **Drug of choice for Radical Cure:** Primaquine (contraindicated in G6PD deficiency and pregnancy).

Practice by Chapter

Principles of Epidemiology

Practice Questions

Measures of Disease Frequency

Practice Questions

Epidemiological Study Designs

Practice Questions

Descriptive Epidemiology

Practice Questions

Analytical Epidemiology

Practice Questions

Experimental Epidemiology

Practice Questions

Screening for Disease

Practice Questions

Surveillance Systems

Practice Questions

Investigation of an Epidemic

Practice Questions

Association and Causation

Practice Questions

Modern Epidemiological Methods

Practice Questions

Critical Appraisal of Epidemiological Studies

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free